Skip to main content
SpringerLink
Log in
Book cover

Human Growth Hormone pp 17–43Cite as

GHRP Historical Perspective

Basic and Clinical

  • Chapter

  • 236 Accesses

Part of the book series: Contemporary Endocrinology ((COE,volume 19))

Abstract

The growth hormone releasing peptides (GHRPs), in contrast to growth hormone releasing hormone (GHRH), were invented rather than discovered. “Reverse pharmacology,” a term recently proposed by Michael Conn, was suggested to designate the developmental GHRP process (1). GHRPs and their mimetics will undoubtedly have a clinical role in the future. Two immediate future objectives of salient importance will be isolation and identification of the putative native hormone for which GHRPs are mimetics and elucidation of its role in the physiological secretion of GH. Moreover, whether this hormone is involved in the pathophysiology of GH deficiency in children and adults is still to be determined.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Conn PM, Bowers CY. A new receptor for growth hormone-release peptide. Science 1996; 273: 923

    Article  PubMed  CAS  Google Scholar 

  2. Currie BL, Johansson KNG, Greibrokk T, Folkers K, Bowers CY. Identification and purification of factor A-GHRH from hypothalami which releases growth hormone. Biochem Biophys Res Comm 1974; 60: 605–609

    Article  PubMed  CAS  Google Scholar 

  3. Johansson KNG, Currie BL, Folkers K, Bowers CY. Identification and purification of factor B-GHRH from hypothalami which releases growth hormone. Biochem Biophys Res Comm 1974; 60: 610–615

    Article  PubMed  CAS  Google Scholar 

  4. Bowers CY, Chang JK, Fong TTW. A synthetic pentapeptide which specifically releases GH, in vitro. 59th Annual Meeting of the Endocrine Society, Chicago, 1997, p. 2332

    Google Scholar 

  5. Bowers CY, Fong TTW, Chang JK. Pituitary hormone releases in vitro by morphine-like peptides. FASEB 1997, p. 311

    Google Scholar 

  6. Bowers CY, Momany F, Chang D, Hong A, Chang K. Structure-activity relationships of a synthetic pentapeptide that specifically releases GH in vitro. Endocrinology 1981; 106 (3): 663–667

    Article  Google Scholar 

  7. Bowers CY, Reynolds GA, Chang D, Hong A, Chang K, Momany F. A study on the regulation of GH release from the pituitary of rats, in vitro. Endocrinology 1981; 108 (3): 1070–1079

    Article  Google Scholar 

  8. Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K. Design, synthesis and biological activity of peptides which release growth hormone, in vitro. Endocrinology 1981; 108 (1): 31–39

    Article  PubMed  CAS  Google Scholar 

  9. Bowers CY, Reynolds GA, Hong A, Momany F. Studies on pituitary cyclic AMP and GH levels and the release of GH in vitro. In: Bhatnager, AS, ed. The Anterior Pituitary Gland. Raven Press, New York, 1983, p. 165–176

    Google Scholar 

  10. Bowers CY, Momany F, Reynolds GA. In vitro and in vivo activity of a small synthetic peptide with potent GH releasing activity. 64th Annual Meeting of the Endocrine Society, San Francisco, 1982, p. 205

    Google Scholar 

  11. Bowers CY, Momany F, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 1984; 114: 1537–1545

    Article  PubMed  CAS  Google Scholar 

  12. Momany F, Bowers CY, Reynolds GA, Hong A, Newlander K. Conformational energy studies and in vitro activity data on active GH releasing peptides. Endocrinology 1984; 114: 1531–1536

    Article  PubMed  CAS  Google Scholar 

  13. Bowers CY, Hubbs JC, Foster CH, Cody WL, Momany FA. US 91/05208

    Google Scholar 

  14. Bowers CY, Coy D. US 92/07026

    Google Scholar 

  15. Momany FA, Bowers CY. Computer-assisted modeling of xenobiotic growth hormone secretagogues. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, p. 73–83

    Chapter  Google Scholar 

  16. Wu D, Chen D, Katoh K, Zhang J, Clarke IJ. The effect of GH-releasing peptide-2 (GHRP-2 or KP102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol 1994; 140: R9 - R13

    Article  PubMed  CAS  Google Scholar 

  17. Bowers CY, Momany F, Reynolds GA, Sartor O. Multiple receptors mediate GH release. 7th International Congress of Endocrinology, Quebec, Canada, 1984, p. 464

    Google Scholar 

  18. Badger RM, Millard WJ, McCormick GF, Bowers CY, Martin JB. The effects of growth hormone (GH) releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 1984; 115: 1432–1438

    Article  PubMed  CAS  Google Scholar 

  19. McCormick GF, Millard WJ, Badger TM, Bowers CY, Martin JB. Dose-response characteristics of various peptides with growth hormone-releasing activity in the unanesthetized male rat. Endocrinology 1985; 117: 97–105

    Article  PubMed  CAS  Google Scholar 

  20. Sartor O, Bowers CY, Chang D. Parallel studies of His-DTrp-Ala-Trp-DPhe-Lys-NH2 and hpGRF-44NH2 in rat primary pituitary cell monolayer culture. Endocrinology 1985; 116: 952–957

    Article  PubMed  CAS  Google Scholar 

  21. Sartor O, Bowers CY, Reynolds GA, Momany F. Variables determining the GH response of His-D-TryAla-Trp-D-Phe-Lys-NH2 (GH-RP-6) in the rat. Endocrinology 1985; 117: 1441–1447

    Article  PubMed  CAS  Google Scholar 

  22. Bowers CY, Sailor O, Reynolds GA, Chang D, Momany F. Evidence that GRF and GRP, His-DTrp-AlaTrp-DPhe-Lys-NH2, act on different pituitary receptors to release GH. 67th Annual Meeting of the Endocrine Society, Baltimore, MD, 1985, p. 38

    Google Scholar 

  23. Bowers CY, Sartor O, Reynolds GA, Chang D. Studies in subhuman primates with growth hormone releasing peptides. 68th Annual Meeting of the Endocrine Society, Anaheim, CA, 1986, p. 146

    Google Scholar 

  24. Reynolds GA, Bowers CY. In vitro studies with GH releasing peptides. 69th Annual Meeting of the Endocrine Society, Indianapolis, 1987, p. 49

    Google Scholar 

  25. Reynolds GA, Momany GA, Bowers CY. Synthetic tetrapeptides that release GH synergistically in combination with GHRP and GHRH. 73rd Annual Meeting of the Endocrine Society, Washington, D.C., 1991, p, 422

    Google Scholar 

  26. Bowers CY, Sartor AO, Reynolds GA, Badger TM. On the actions of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 1991; 128: 2027–2035

    Article  PubMed  CAS  Google Scholar 

  27. Bowers CY. Atypical growth hormone releasing peptides. In: Bercu B, Walker R, eds. Growth Hormone II: basic and clinical aspects. Springer-Verlag, New York, 1994, pp. 203–222

    Google Scholar 

  28. Chihara K, Kaji H, Hayashi S, Yagi H, Takeshima Y, Mitani M, et al. Growth hormone releasing hexapeptide: basic research and clinical application. In: Bercu B, Walker R, eds. Growth Hormone II: basic and clinical aspects. Springer-Verlag, New York, 1994, pp. 223–230

    Google Scholar 

  29. Cheng K, Chan WWS, Barreto A, Convey EM, Smith RG. The synergistic effects of His-D-Trp-AlaTrp-D-Phe-Lys-NH2 on growth hormone (GH) releasing factor-stimulated GH release and intracellular adenosine 3’,5’-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989; 124: 2791–2798

    Article  PubMed  CAS  Google Scholar 

  30. Bitar KG, Bowers CY, Coy DH. Effects of substance P/bombesin antagonists on the release of growth hormone by GHRP and GHRH. Biochem Biophys Res Comm 1991; 180 (1): 156–161

    Article  PubMed  CAS  Google Scholar 

  31. Sethumadhavan K, Veeraragavan K, Bowers CY. Demonstration and characterization of the specific binding of growth hormone-releasing peptide (GHRP) to rat anterior pituitary and hypothalamic membranes. Biochem Biophys Res Comm 1991; 178 (1): 31–37

    Article  PubMed  CAS  Google Scholar 

  32. Clark RG, Carlsson LMS, Trohnar J, Robinson ICAF. The effects of a growth hormone releasing peptide and growth hormone releasing factor in conscious and anesthetized rats. J Neuroendocrinol 1989; 1: 249–255

    Article  PubMed  CAS  Google Scholar 

  33. Codd EE, Shu AYL, Walker RF. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary sites. Neuropharmacology 1989; 28: 1139–1144

    Article  PubMed  CAS  Google Scholar 

  34. Dickson SL, Leng G, Robinson ICAF. Systemic administration of growth hormone releasing peptide activates hypothalamic arcuate neurons. Neuroscience 1993; 53 (2): 303–306

    Article  PubMed  CAS  Google Scholar 

  35. Dickson SL. Evidence for a central site and mechanism of action of growth hormone releasing peptide (GHRP-6). In: Bercu B, Walker R, eds. Growth Hormone II: Basic and Clinical Aspects. Spring-Verlag, New York, 1991, pp. 237–251

    Google Scholar 

  36. Dickson SL, Luckman SM. Induction of c fos mRNA in NPY and GRF neurons in the rat arcuate nucleus following systemic injection of the growth hormone secretagogue, GHRP-6. Endocrinology 1997; 138: 771–777

    Article  PubMed  CAS  Google Scholar 

  37. Guillaume V, Magnan E, Cataldi M, Dutour A, Sauze N, Renard M, et al. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinol 1994; 135: 1073–1075

    Article  CAS  Google Scholar 

  38. Mallo F, Alvarez CV, Benitez L, Burguera B, Coya R, Casanueva FF, et al. Regulation of His-dTrp-AlaTrp-dPhe-Lys-NH2 (GHRP-6) induced GH secretion in the rat. Neuroendocrinology 1992; 57: 247–251

    Article  Google Scholar 

  39. Korbonits M, Trainer PJ, Besser GM. The effect of an opiate antagonist on the hormonal changes induced by hexarelin. Clin Endocrinol 1995; 43: 365–371

    Article  CAS  Google Scholar 

  40. Smith RG, Pong SS, Hickey G, Jacks T, Cheng K, Leonard R, et al. Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 1996; 51: 261–286

    PubMed  CAS  Google Scholar 

  41. Adams EF, Bowers CY. Protein Kinase c-dependent growth hormone releasing peptides stimulate cAMP production by human pituitary somatotrophinomas expressing GSP oncogenes: evidence for cross-talk between transduction pathways. Molecular Endocrinology 1996; 10: 432–438

    Article  PubMed  CAS  Google Scholar 

  42. Mau SE, Witt MR, Bjerrum OJ, Searmark T, Vilhardt H. Growth hormone releasing hexapeptide (GHRP-6) activates the inositol (1,4,5)-triphosphate/diacylglycerol pathway in rat anterior pituitary cells. J Recept Signal Tranduct Res 1995; 15: 311–323

    Article  CAS  Google Scholar 

  43. Leonard RJ, Chaung LYP, Pong SS. Ionic conductances of identified rat somatotroph cells studied by perforated patch recording are modulated by growth hormone secretagogues. Biophys J 1991; 59: a254

    Google Scholar 

  44. Pong SS, Chaung LY, Smith RG, Ertel E, Smith MM, Cohen CJ. Role of calcium channels in growth hormone secretion induced by GHRP-6 (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2) and other secretagogues in rat somatotrophs. 74th Annual Meeting of the Endocrine Society, San Antonio, TX, 1992, p. 255

    Google Scholar 

  45. Herrington J, Hille JB. Growth hormone-releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms. Endocrinology 1994; 135: 1100–1108

    Article  PubMed  CAS  Google Scholar 

  46. Chen C, Wu D, Clarke U. Signal transduction systems employed by synthetic GH-releasing peptides in somatotrophs. J Endocrinol 1996; 148: 381–386

    Article  PubMed  CAS  Google Scholar 

  47. Bowers CY, Reynolds GA, Durham D, Barrera DM, Pezzoli SS, Thorner MO. Growth hormone releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 1990; 70: 975–982

    Article  PubMed  CAS  Google Scholar 

  48. Ilson BE, Jorkasky DK, Curnow RT, Stote RM. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J Clin Endocrinol Metab 1989; 69: 212–214

    Article  PubMed  CAS  Google Scholar 

  49. Huhn WC, Hartman ML, Pezzoli SS, Thorner MO. 24-h growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. J Clin Endocrinol Metab 1993;76:1201–1208

    Google Scholar 

  50. Jaffe CA, Ho J, Demott-Friberg R, Bowers CY, Barkan AL. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men. J Clin Endocrinol Metab 1993; 77: 1641–1647

    Article  PubMed  CAS  Google Scholar 

  51. Deghenghi R. Growth hormone releasing peptides. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, pp. 85–102

    Chapter  Google Scholar 

  52. Ghigo E, Arvat E, Gianotti L, Grottoli S, Rizzi G, Ceda G, Deghenghi R, Camanni F. Aging and growth hormone releasing peptides. In: Bercu B, Walker R, eds. Spring-Verlag, New York, 1996, pp. 415–431

    Google Scholar 

  53. Walker R, Bercu B Animal models for evaluating xenobiotic growth hormone secretagogue activity. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, pp. 253–287

    Chapter  Google Scholar 

  54. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T, et al. A novel non-peptidyl growth hormone secretagogue. Science 1993; 260: 1640–1632

    Article  PubMed  CAS  Google Scholar 

  55. Pong SS, Chaung LYP, Dean DC, Nargund RP, Patchett AA, Smith RG. Identification of a new G-protein-linked receptor for growth hormone secretagogues. Mol Endocrinol 1996; 10: 57–61

    Article  PubMed  CAS  Google Scholar 

  56. Patchett AA, Nargund RP, Tata JR, Chen MH, Barakat KJ, Johnston DBR, et al. Design and biological activities of L-163–191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA 1995; 92: 7001–7005

    Article  PubMed  CAS  Google Scholar 

  57. McDowell RS, Elias KA, Stanley MS, Burdick DJ, Burnier JP, Chan KS, et al. Growth hormone secretotogues: characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA 1995;92:11, 165–11, 169

    Google Scholar 

  58. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, et al. In vitro characterization of four novel classes of growth hormone releasing peptide. Endocrinology 1995; 136: 5694–5699

    Article  PubMed  CAS  Google Scholar 

  59. Johansen NL, Hansen BS, Klitgaard H, Ankerson M. Structure activity relationship of GHRP analogs. 10th International Congress of Endocrinology, San Francisco, 1996, p. 281

    Google Scholar 

  60. Johansen NL, Lau J, Madsen K, Lundt B, Thogersen H, Peschke B. WO95/17423 and WO95/17422

    Google Scholar 

  61. Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R. Pituitary responsiveness to growth hormone (GH)-releasing hormone, GH-releasing peptide-2 (GHRP-2) and thyrotropin-releasing hormone in critical illness. Clin Endocrinol 1996; 45: 341–351

    Article  Google Scholar 

  62. Van den Berghe G, de Zegher F, Velduis JD, Wouters P, Awouters M, Vergruggen W, Schetz M, Verwaest C, Lauwers P, Buoillon R, Bowers CY. The somatotropic axis in critical illness: effect of continuous GHRH and GHRP-2 infusion. J Clin Endocrinol Metab 1997; 82: 590–599

    Article  PubMed  Google Scholar 

  63. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996; 273: 972–977

    Article  Google Scholar 

  64. Bowers CY. Overview: Xenobiotic growth hormone secretagogues: growth hormone releasing peptides (GHRP)s. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, p. 9–28

    Chapter  Google Scholar 

  65. Bowers CY, Reynolds GA, Field G, Arkieh A, Kaf-Alghazal A, Krishnamurthi L, Granda-Ayala R. Independency, dependency and synergism of GHRP-2 and GHRH on GH release in humans. 10th International Congress of Endocrinology, San Francisco, 1996, p. 770

    Google Scholar 

  66. Fairhall KM, Mynett A, Thomas GB, Robinson ICAF. Central and peripheral effects of peptide and nonpeptide GH secretagogues on GH release in vivo. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, pp. 219–236

    Chapter  Google Scholar 

  67. Thorner MO, Vance ML, Rogol AD, Blizzard RM, Veldhuis JD, Carter EV, Copinschi G, Bowers CY. Growth hormone-releasing hormone and growth hormone-releasing peptide as potential therapeutic modalities. Acta Paediatr Scand [Suppl] 1990; 367: 29–32

    Article  CAS  Google Scholar 

  68. Bowers CY, Newell D, Granda-Ayala R, Garcia M, Barrera C. Comparative studies on GH release in younger and older men and women. 74th Annual Meeting of the Endocrine Society, San Antonio, TX, 1992, p. 172

    Google Scholar 

  69. Pihoker C, Middleton R, Reynolds GA, Bowers CY, Badger TM. Diagnostic studies with intravenous and intranasal growth hormone releasing peptide-2 in children of short stature. J Clin Endocrinol Metab 1995; 80: 2987–2992

    Article  PubMed  CAS  Google Scholar 

  70. Laron Z, Bowers CY, Hirsch D, Almonte AS, Pelz M, Keret R, et al. Growth hormone-releasing activity of growth hormone releasing peptide-1 (a synthetic heptapeptide) in children and adolescents. Acta Endocrinol 1993; 129: 424–426

    PubMed  CAS  Google Scholar 

  71. Laron Z, Frenkel J, Silbergeld A. Growth hormone releasing peptide-hexarelin-in children. Biochemical and growth promoting effects. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, pp. 379–387

    Chapter  Google Scholar 

  72. Pihoker C, Badger TM, Reynolds GA, Bowers CY. Treatment effects of intranasal growth hormone releasing peptide-2 in children with short stature. J Endocrinol 1997; 155: 79–86

    Article  PubMed  CAS  Google Scholar 

  73. Mericq V, Cassorla F, Salazar T, Avila A, Iniguez G, Merriam G, et al. Increased growth velocity during prolonged GHRP-2 administration to growth hormone deficient children. 77th Annual Meeting of the Endocrine Society, Washington, DC, 1991, p. 85

    Google Scholar 

  74. Casanueva FF, Popovic V, Leal-Cerro A, Zugaza JL, Pombo M, Dieguez C. Growth hormone secretagogues in disease states associated with altered growth hormone secretion: In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, pp. 389–401

    Google Scholar 

  75. Renner U, Brockmeier S, Strasburger CJ, Lange M, Schopohl J, Muller OA, et al. Growth hormone (GH) releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and octreotide. J Clin Endocrinol Metab 1994; 78: 1090–1096

    Article  PubMed  CAS  Google Scholar 

  76. Alster DK, Bowers CY, Jaffe CA, Ho PJ, Barkan AL. The GH response to GHRP (His-DTrp-Ala-TrpDPhe-Lys-NH2) GHRH and TRH in acromegaly. J Clin Endocrinol Metab 1993; 77: 842–845

    Article  PubMed  CAS  Google Scholar 

  77. Bowers CY, Granda-Ayala R, Almed B, Servera S, Reyes Y, Baquet T, Zia T, Fertig B. On the chronic administration of GHRP-2 to normal men and women. 77th Annual Meeting of the Endocrine Society, Washington, DC, 1995, p. 502

    Google Scholar 

  78. Bowers CY. Clinical implications of changes in growth hormone with aging. In: Bray G, Ryan R, eds. Nutrition, Endocrinology and Disease, Vol. IV. Pennington Nutrition Series. Baton Rouge, LSU Press, 1995; pp. 69–84

    Google Scholar 

  79. Bercu B, Walker RF. A diagnostic test employing growth hormone secretagogues for evaluating pituitary function in the elderly. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Springer-Verlag, New York, 1996, pp. 289–305

    Chapter  Google Scholar 

  80. Bowers CY, Granda-Ayala R. GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans. International Symposium on Growth, October 18–20, 1995, Santiago de Compostela, Spain. J Pedia Endo Metab 1996;9(3): 261–270

    Google Scholar 

  81. Bowers CY. GHRP+GHRH Synergistic Release of GH: Scope and Implication. In: Bercu B, Walker R, eds. Growth Hormone Secretagogues. Marcel Dekker, New York, 1998, pp. 1–25

    Google Scholar 

Download references

Authors
  1. C. Y. Bowers MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Huffington Center on Aging and Department of Cell Biology, Baylor College of Medicine, Houston, TX, USA

    Roy G. Smith PhD

  2. Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, VA, USA

    Michael O. Thorner MD

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.,Totowa,NJ

About this chapter

Cite this chapter

Bowers, C.Y. (2000). GHRP Historical Perspective. In: Smith, R.G., Thorner, M.O. (eds) Human Growth Hormone. Contemporary Endocrinology, vol 19. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-015-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-015-5_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9610-9

  • Online ISBN: 978-1-59259-015-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation